Dermata Therapeutics (DRMA) Interest Coverage Ratio (2020 - 2025)
Dermata Therapeutics (DRMA) posted quarterly Interest Coverage Ratio of 3.34 for Q1 2025, up 6.09% year-over-year from 3.15 in Q1 2024, and down 35.78% quarter-over-quarter from 2.46 in Q4 2024.
Dermata Therapeutics (DRMA) Interest Coverage Ratio (2020 - 2025) Analysis & Trends
Dermata Therapeutics' Interest Coverage Ratio history runs 6 years deep, the most recent figure standing at 3.34 for Q1 2025.
- In Q1 2025, Interest Coverage Ratio rose 6.09% year-over-year to 3.34; the TTM figure through Dec 2025 stood at 11.11 (down 396.98% YoY), while the FY2025 annual figure was 11.11, down 611.31% from the prior year.
- Interest Coverage Ratio for Q1 2025 stood at 3.34, down from 2.46 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 1.79 in Q3 2024, with the low at 2630.21 in Q3 2021.
- The 5-year median for Interest Coverage Ratio is 8.75 (2024), against an average of 345.63.
- The sharpest annual moves came in 2021 and 2024: Interest Coverage Ratio tumbled 27822.36% in 2021, then soared 85.69% in 2024.
- Dermata Therapeutics' Interest Coverage Ratio stood at 2630.21 in 2021, then soared by 99.47% to 13.93 in 2022, then declined by 23.53% to 17.21 in 2023, then jumped by 85.69% to 2.46 in 2024, then plunged by 35.78% to 3.34 in 2025.
- Business Quant data shows DRMA's Interest Coverage Ratio at 3.34 in Q1 2025, 2.46 in Q4 2024, and 1.79 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Dermata Therapeutics | 5.40 Mn | 5.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -3.34 |
| Dec 31, 2024 | -2.46 |
| Sep 30, 2024 | -1.79 |
| Jun 30, 2024 | -1.80 |
| Mar 31, 2024 | -3.56 |
| Dec 31, 2023 | -17.21 |
| Mar 31, 2022 | -13.93 |
| Sep 30, 2021 | -2,630.21 |
| Jun 30, 2021 | -729.55 |
| Mar 31, 2021 | -52.43 |
| Dec 31, 2020 | -88.42 |
| Sep 30, 2020 | -9.42 |
| Jun 30, 2020 | -27.47 |